Wentworth Kory James

Chief Financial Officer

1 company

Good

Trades Analyzed

12M Win Rate

48.1%

Avg 3M Return

+4.3%

Avg 12M Return

+6.4%

Wentworth Kory James is a Chief Financial Officer at Entrada Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 16 sells.

Estimated insider holdings value: $862K based on current market prices.

Holdings by Company

TRDAMar 10, 2026

Current Shares121.5K

Value$861.5K

Net Activity-118,328

Bought: 0Sold: 118.3K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 10, 2026	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sell	16,477	$13.01	$214,378.56	-6.1%	-	-
Nov 21, 2025	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sell	8,910	$9.98	$88,931.60	-7.5%	+12.9%	-
Mar 17, 2025	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sell	1,784	$10.67	$19,035.28	-1.6%	-31.5%	+16.5%
Dec 2, 2024	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sale+OE	6,000	$19.99	$119,948.30	-3.9%	-44.2%	-51.5%
Nov 11, 2024	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sale+OE	8,637	$19.98	$172,562.08	-10.5%	-35.3%	-61.3%
Sep 9, 2024	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sell	3,195	$14.97	$47,832.35	-4.0%	+43.2%	-65.8%
Jul 8, 2024	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sell	1,758	$14.95	$26,282.10	-2.1%	+9.2%	-52.7%
Mar 6, 2024	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sell	4,086	$12.31	$50,285.18	-5.2%	+23.5%	-15.9%
Dec 26, 2023	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sale+OE	12,500	$15.59	$194,845.26	-5.8%	-19.8%	+6.3%
Sep 6, 2023	TRDA Entrada Therapeutics, Inc.	Chief Financial Officer	Sell	950	$13.48	$12,806.17	-0.9%	+1.2%	+10.9%